Avidity Partners Management LP 13D and 13G filings for Altimmune, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 06:37 am Sale | 2023-12-31 | 13G | Altimmune, Inc. ALT | Avidity Partners Management LP | 0 0.000% | -3,990,000 (Position Closed) | Filing |
| 2023-02-14 3:49 pm Purchase | 2022-12-31 | 13G | Altimmune, Inc. ALT | Avidity Partners Management LP | 3,990,000 8.100% | 1,225,000 (+44.30%) | Filing |
| 2022-01-03 12:07 pm Purchase | 2021-12-30 | 13G | Altimmune, Inc. ALT | Avidity Partners Management LP | 2,765,000 7.000% | 2,765,000 (New Position) | Filing |